📰 Synlogic Inc News
Page 7 - Synlogic Inc News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Synlogic Inc. Real-time updates on events, politics, business and more.
March 29, 2023
Synlogic Reports Fourth Quarter and Full Year 2022 Financial Results and Corporate Updates - Phenylketonuria program on track for Phase 3 trial initiation in first half of 2023... | March 29, 2023
March 29, 2023
– Phenylketonuria program on track for Phase 3 trial initiation in first half of 2023 – – Rare Pediatric Disease Designation granted for SYNB1934 for PKU and... | March 29, 2023
March 29, 2023
– Phenylketonuria (PKU) program on track for Phase 3 trial initiation in first half of 2023 – – Rare Pediatric Disease Designation granted for SYNB1934...
March 29, 2023
Item 2.02 Results of Operations and Financial Condition. On March 29, 2023, Synlogic, Inc. announced its financial results for the quarter and full year ended December 31, 2022. The full text of the... | March 29, 2023
March 29, 2023
Analysts’ updated eps estimates for Wednesday, March 29th: Boliden AB (publ) (OTCMKTS:BDNNY) was downgraded by analysts at Morgan Stanley from an equal weight rating to an underweight rating. Robert W. Baird began coverage on shares of Crinetics Pharmaceuticals (NASDAQ:CRNX). Robert W. Baird issued an outperform rating on the stock. Mizuho assumed coverage on shares of […]
March 28, 2023
CAMBRIDGE, Mass., March 28, 2023 -- Synlogic, Inc. , the leading company advancing therapeutics based on synthetic biology, today announced that the European Medicines Agency issued a... | March 28, 2023
March 28, 2023
CAMBRIDGE, Mass., March 28, 2023 (GLOBE NEWSWIRE) -- Synlogic, Inc. (Nasdaq: SYBX), the leading company advancing therapeutics based on synthetic...
February 21, 2023
/PRNewswire/ -- The microbiomes market report has been published by Technavio. Market growth is estimated to accelerate at a CAGR of 21.95% and register an...
February 1, 2023
SYNTHETIC BIOTICS AS A VERSATILE PLATFORM TO TREAT INFLAMMATORY BOWEL DISEASE Bat-Erdene Jugder, Jenny Shu, Analise Reeves, Anna Sokolovska,... | February 1, 2023
January 31, 2023
/PRNewswire/ -- PreciseDx, a leading innovator in AI-powered, patient-specific disease analysis, today announced the appointment of Paul Roma as Chairman of...